Corrigendum to "Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats" [Neurosci. Lett. 584 (2015) 276–281]. (5th February 2015) - Suzuki, Syuuichirou